You just read:

Swedish Orphan Biovitrum AB - Orfadin® Capsules Approved in the Kingdom of Saudi Arabia for the Treatment of Hereditary Tyrosinemia Type 1

News provided by

Swedish Orphan Biovitrum AB

May 17, 2017, 03:15 ET